概括
评估心力衰竭 (HF) 患者的情况.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 临床评估 临床评估
背景情况:
- 目前的心力衰竭 (HF) 准则建议使用四种临床概况进行血液动力学评估.
- 由于缺乏简单的物理指标,评估患者的输液状态往往被忽视.
- perfusion index (PI) 提供了一种非侵入性的方法来评估血液流动的动态.
研究的目的:
- 评估外周 perfusion 指数 (PI) 在评估急性心力衰竭 (HF) 患者的 perfusion 状态时的有用性.
- 为了确定外围PI是否可以帮助HF患者的风险分层.
主要方法:
- 一项针对257名住院急性HF患者的前性研究.
- 周围PI在出院前在食指上测量.
- 对所有原因死亡率和HF住院住院的复合结果的随访.
主要成果:
- 患有冷 perfusion 个人资料的患者表现出更高的不良结果发生率 (HR 1.98).
- 外围PI <1.1与风险增加有关 (HR 2.27).
- 这些发现在各个子组分析中是一致的.
结论:
- 退院前的边缘PI评估是HF风险分层的一个简单,实用的工具.
- 外围PI提供了与 perfusion 状态的传统临床标准相比较的预后价值.
相关概念视频
Heart Failure II: Pathophysiology
993
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
993
Pathophysiology of Heart Failure
3.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.9K
Heart Failure I: Introduction
947
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
947
Heart Failure VI: Adjunct Therapies
391
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
391
Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management
356
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
356


